TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2841839

Group type: EXPERIMENTAL
Intervention: High-carbohydrate, high-fiber diet
Number of subjects: 6

Group type: COMPARATOR
Intervention: Low-carbohydrate, low-fiber diet
Number of subjects: 6
Study: 29458316

Group type: EXPERIMENTAL
Intervention: Energy-dense formulation (1.5 kcal/mL)
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Routine enteral feed formulation (1 kcal/mL)
Number of subjects: 4000
Study: 26580691

Group type: EXPERIMENTAL
Intervention: MAX intervention group (n = 20)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Health Education group (n = 21)
Number of subjects: 41
Study: 24655814

Group type: EXPERIMENTAL
Intervention: Behaviour change counselling intervention (glaucoma education and motivational support package)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Standard clinical care (control group)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Behaviour change counselling intervention
Number of subjects: 208
Study: 22718559

Group type: EXPERIMENTAL
Intervention: Informational film about prenatal examinations
Number of subjects: 390

Group type: COMPARATOR
Intervention: Control group (no informational film)
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Informational film
Number of subjects: 390
Study: 20047573

Group type: EXPERIMENTAL
Intervention: Hypersomnia patients
Number of subjects: 2208

Group type: COMPARATOR
Intervention: Controls (age and gender adjusted citizens)
Number of subjects: 2208
Study: 19211941

Group type: EXPERIMENTAL
Intervention: Failure training (3 sets to voluntary exhaustion)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonfailure training (4 sets with submaximal repetitions)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (Failure and Nonfailure)
Number of subjects: 0
Study: 15142025

Group type: EXPERIMENTAL
Intervention: Heavy dynamic preload (1 set of 5 repetition maximum back squats)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 5RM back squat
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Dynamic preload exercise protocol
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Repeated exposure to heavy dynamic preload exercise protocol
Number of subjects: 19
Study: 11486642

Group type: EXPERIMENTAL
Intervention: Egoism priming
Number of subjects: 0

Group type: COMPARATOR
Intervention: Altruism priming
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral priming
Number of subjects: 0
Study: 9595924

Group type: EXPERIMENTAL
Intervention: Tamoxifen 10 mg by mouth from day 5 to day 24 of the menstrual cycle
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo 10 mg by mouth from day 5 to day 24 of the menstrual cycle
Number of subjects: 88
Study: 8071049

Group type: EXPERIMENTAL
Intervention: Iopromide (300 mg I/kg)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ioversol (300 mg I/kg)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Iopamidol (300 mg I/kg)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Iopromide, Ioversol, Iopamidol
Number of subjects: 200
Study: 2895662

Group type: EXPERIMENTAL
Intervention: Active treatment (bendrofluazide or propranolol)
Number of subjects: 17354

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17354

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 17354

Group type: EXPERIMENTAL
Intervention: Bendrofluazide
Number of subjects: 17354

Group type: COMPARATOR
Intervention: Placebo (in smokers)
Number of subjects: 17354
Study: 29253463

Group type: EXPERIMENTAL
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 937

Group type: EXPERIMENTAL
Intervention: SAVR
Number of subjects: 937
Study: 28084056

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 26602538

Group type: EXPERIMENTAL
Intervention: Vibrotactile feedback
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Joint torque feedback
Number of subjects: 10

Group type: COMPARATOR
Intervention: No feedback
Number of subjects: 10
Study: 24392599

Group type: EXPERIMENTAL
Intervention: Twice-daily insulin lispro mix 75/25 (LM75/25)
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Once daily insulin glargine (GL)
Number of subjects: 2000
Study: 22005624

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA) measured by accelerometry
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Sedentary time measured by accelerometry
Number of subjects: 337
Study: 18689149

Group type: EXPERIMENTAL
Intervention: Type 1 diabetes patients with good glycemic control (HbA1c ≤ 8%)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Type 1 diabetes patients with poor glycemic control (HbA1c > 8%)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 30
Study: 16879519

Group type: COMPARATOR
Intervention: N2O/O2-fentanyl
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: N2O/O2-sevoflurane
Number of subjects: 24
Study: 14976918

Group type: EXPERIMENTAL
Intervention: ALA-fluorescence
Number of subjects: 102

Group type: COMPARATOR
Intervention: White light
Number of subjects: 102
Study: 10696631

Group type: EXPERIMENTAL
Intervention: Structured lipid emulsion
Number of subjects: 22

Group type: COMPARATOR
Intervention: Long-chain triacylglycerol emulsion
Number of subjects: 22
Study: 9175175

Group type: COMPARATOR
Intervention: Powdered ginger 4 g daily for 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single dose of powdered ginger 10 g
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fenugreek 2.5 g twice daily for 3 months to healthy individuals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fenugreek 2.5 g twice daily for 3 months to CAD patients with NIDDM
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fenugreek 2.5 g twice daily for 3 months to NIDDM (non-CAD) patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fenugreek 2.5 g twice daily for 3 months to severe NIDDM cases
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fenugreek administration
Number of subjects: 0
Study: 8439216

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Prolonged glucose administration (250-300 g/day)
Number of subjects: 300
Study: 3812050

Group type: EXPERIMENTAL
Intervention: Cigarette discrimination task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cigarette sweetness ratings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotine, tar, and carbon monoxide
Number of subjects: 0
Study: 31331582

Group type: EXPERIMENTAL
Intervention: So-Cheong-Ryong-Tang (SCRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29988125

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26596973

Group type: EXPERIMENTAL
Intervention: romiplostim
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: eltrombopag
Number of subjects: 124
Study: 24879888

Group type: EXPERIMENTAL
Intervention: Fat-burning exercise
Number of subjects: 96

Group type: COMPARATOR
Intervention: Endurance exercise
Number of subjects: 96
Study: 22481647

Group type: EXPERIMENTAL
Intervention: Nail lacquer containing ciclopirox 8% applied once weekly
Number of subjects: 41

Group type: COMPARATOR
Intervention: Nail lacquer containing ciclopirox 8% applied using the traditional regimen (3/2/1)
Number of subjects: 41
Study: 20154483

Group type: EXPERIMENTAL
Intervention: Oral beclomethasone dipropionate (BDP) administration
Number of subjects: 5
Study: 18584525

Group type: EXPERIMENTAL
Intervention: Triple antiviral induction therapy: amantadine hydrochloride and ribavirin, combined with 6 weeks interferon alfa‐2b (weeks 1‐2: 18 MU/day, weeks 3‐4: 9 MU/day, weeks 5‐6: 6 MU/day), thereafter combined with weekly peginterferon alfa‐2b
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Fast responders treated for 24 weeks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Fast responders treated for 48 weeks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Treatment-naive patients with HCV RNA <5 IU/mL at week 1 or 2
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Treatment-naive patients with HCV RNA >or=5 IU/mL at week 16
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Previous non‐responders/relapsers with HCV RNA <5 IU/mL at week 2
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Previous non‐responders/relapsers with HCV RNA >or=5 IU/mL at week 8
Number of subjects: 100
Study: 15319016

Group type: EXPERIMENTAL
Intervention: OROS methylphenidate (MPH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MPH tid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: OROS MPH (during the first year of the open-label study)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: OROS MPH
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: History of tics
Number of subjects: 0
Study: 11059861

Group type: COMPARATOR
Intervention: Intravenous ciprofloxacin 200 mg/12 h for 7 days (group A)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intravenous ciprofloxacin 200 mg/12 h for 2 days followed by oral ciprofloxacin 500 mg/12 h for 5 days (group B)
Number of subjects: 80
Study: 9082266

Group type: EXPERIMENTAL
Intervention: Rectal acetaminophen
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intravenous fentanyl-droperidol
Number of subjects: 90
Study: 8375123

Group type: EXPERIMENTAL
Intervention: Oral morphine administration
Number of subjects: 6

Group type: COMPARATOR
Intervention: Rectal morphine administration
Number of subjects: 6
Study: 3532469

Group type: EXPERIMENTAL
Intervention: CMFH (CMF plus homoharringtonine)
Number of subjects: 92

Group type: COMPARATOR
Intervention: CMF (cyclophosphamide, methotrexate, fluorouracil)
Number of subjects: 92

Group type: COMPARATOR
Intervention: CMF
Number of subjects: 92
Study: 31277165

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (3 cycles of combination therapy with carboplatin and nab‐paclitaxel)
Number of subjects: 25
Study: 27890714

Group type: EXPERIMENTAL
Intervention: Amikacin Fosfomycin Inhalation System (AFIS) - 300 mg amikacin/120 mg fosfomycin, delivered by aerosol twice daily for 10 days (or to extubation if < 10 days) via the investigational eFlow Inline System.
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo (saline), delivered by aerosol twice daily for 10 days (or to extubation if < 10 days) via the investigational eFlow Inline System.
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Amikacin Fosfomycin Inhalation System (AFIS)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 143
Study: 25651955

Group type: EXPERIMENTAL
Intervention: Sutures
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Absorbable mesh (Surgisis)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Non-absorbable mesh (Timesh)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Overall (all groups)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Overall (recurrence analysis)
Number of subjects: 126
Study: 24316218

Group type: EXPERIMENTAL
Intervention: Treadmill CPET
Number of subjects: 55

Group type: COMPARATOR
Intervention: Cycle CPET
Number of subjects: 55
Study: 23017827

Group type: EXPERIMENTAL
Intervention: REPYFLEC cognitive remediation group training
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (activities without specific objectives and focused on leisure)
Number of subjects: 62
Study: 19543195

Group type: EXPERIMENTAL
Intervention: CAS with Cutting-Balloon Angioplasty (CBA)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Standard CAS
Number of subjects: 102
Study: 17292412

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention
Number of subjects: 227

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: NK-stimulatory cytokines (IL-2, IL-12, IL-15)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Media alone or with IL-2
Number of subjects: 227
Study: 15064259

Group type: EXPERIMENTAL
Intervention: 5-HT3 receptor antagonists combined with droperidol
Number of subjects: 3447

Group type: EXPERIMENTAL
Intervention: 5-HT3 receptor antagonists combined with dexamethasone
Number of subjects: 3447

Group type: COMPARATOR
Intervention: 5-HT3 receptor antagonists alone
Number of subjects: 3447
Study: 11192362

Group type: EXPERIMENTAL
Intervention: Metoprolol CR/XL (200 mg once daily)
Number of subjects: 3991
Study: 9088814

Group type: COMPARATOR
Intervention: Controlled hypotension alone (Group A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Haemodilution alone (Group B)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Controlled hypotension and haemodilution (Group C)
Number of subjects: 30
Study: 8478543

Group type: EXPERIMENTAL
Intervention: Patient telephone surveys
Number of subjects: 501

Group type: COMPARATOR
Intervention: Traditional surveillance system and monthly physician questionnaires
Number of subjects: 501
Study: 3823636

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg/kg body weight; equivalent to approximately 4 cups of coffee)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 30287240

Group type: EXPERIMENTAL
Intervention: Mediterranean diet adherence (11-17 points)
Number of subjects: 6874

Group type: EXPERIMENTAL
Intervention: Mediterranean diet adherence (upper third)
Number of subjects: 6874

Group type: COMPARATOR
Intervention: Low adherence to Mediterranean diet (≤ 7 points)
Number of subjects: 6874
Study: 28817223

Group type: COMPARATOR
Intervention: MK-1293
Number of subjects: 185

Group type: COMPARATOR
Intervention: EU-Lantus
Number of subjects: 185

Group type: COMPARATOR
Intervention: US-Lantus
Number of subjects: 185
Study: 27338460

Group type: EXPERIMENTAL
Intervention: Dairy-based beverage (DBB)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Carbohydrate beverage (CHO)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Water control (H2O)
Number of subjects: 13
Study: 25668387

Group type: EXPERIMENTAL
Intervention: Virtual reality-based balance training program (postural stability training program using the Biodex Balance System SD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study: 23936886

Group type: EXPERIMENTAL
Intervention: Multifaceted knowledge translation intervention consisting of interactive education, mentorship through quality circles, and practice-based tools.
Number of subjects: 0
Study: 21352575

Group type: EXPERIMENTAL
Intervention: Hartslag Limburg intervention (n = 2356)
Number of subjects: 2356

Group type: COMPARATOR
Intervention: Reference group (n = 758)
Number of subjects: 2356
Study: 18301772

Group type: EXPERIMENTAL
Intervention: Communicable diseases
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Maternal, perinatal, and nutritional conditions
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Non-communicable diseases
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Injuries
Number of subjects: 66
Study: 17020971

Group type: EXPERIMENTAL
Intervention: TT genotype
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: TC genotype
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: CC genotype
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: ZAP-70 positive CC genotypes
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: T-alleles
Number of subjects: 144
Study: 14617471

Group type: EXPERIMENTAL
Intervention: Ketamine general anaesthesia with 0.6 mg atropine and 10 mg diazepam premedication
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Ketamine general anaesthesia with 0.6 mg atropine and 50 mg promethazine premedication
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Ketamine general anaesthesia with only 0.6 mg atropine
Number of subjects: 295

Group type: COMPARATOR
Intervention: Ketamine general anaesthesia
Number of subjects: 295
Study: 11035130

Group type: EXPERIMENTAL
Intervention: Folic acid 5 mg daily
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 9173652

Group type: EXPERIMENTAL
Intervention: Hypovolemic haemodilution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normovolemic haemodilution with Ringer solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normovolemic haemodilution with 6% hydroxyethyl starch
Number of subjects: 0
Study: 1405316

Group type: COMPARATOR
Intervention: Cuprophan membranes (hemodialyzed patients)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Control subjects
Number of subjects: 25
Study: 30823952

Group type: EXPERIMENTAL
Intervention: Inhaled glucocorticoid combined with tiotropium bromide
Number of subjects: 86

Group type: COMPARATOR
Intervention: Inhaled glucocorticoid
Number of subjects: 86
Study: 28044450

Group type: EXPERIMENTAL
Intervention: 200 mg caffeine
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 200 mg theanine
Number of subjects: 36

Group type: COMPARATOR
Intervention: 200 mg caffeine + 200 mg theanine
Number of subjects: 36

Group type: COMPARATOR
Intervention: 0 mg caffeine + 0 mg theanine (placebo)
Number of subjects: 36
Study: 25366866

Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Combined intervention
Number of subjects: 38

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 38
Study: 24912486

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional oxygen therapy (OT)
Number of subjects: 0
Study: 21388828

Group type: EXPERIMENTAL
Intervention: Tinzaparin
Number of subjects: 1220

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 1220
Study: 19687032

Group type: EXPERIMENTAL
Intervention: Remifentanil (Group R) - continuous infusion titrated between 3 and 4 ng ml‐1
Number of subjects: 80

Group type: COMPARATOR
Intervention: Magnesium sulphate (Group M) - i.v. bolus of 50 mg kg‐1 followed by a 15 mg kg‐1 h ‐1 continuous infusion
Number of subjects: 80
Study: 17490862

Group type: EXPERIMENTAL
Intervention: Metformin (850 to 2550 mg daily)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 80
Study: 16270291

Group type: EXPERIMENTAL
Intervention: Application of external heat to the anterior aspect of the knee (heated knee)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Contralateral knee (control)
Number of subjects: 8
Study: 12133054

Group type: EXPERIMENTAL
Intervention: Interviewer-administered questionnaire
Number of subjects: 930
Study: 10210574

Group type: EXPERIMENTAL
Intervention: Stimulated mTF levels in patients with bladder and prostate malignancy
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Baseline mTF levels in benign inflammatory groups
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Stimulated mTF levels
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: mTF levels in patients with bladder cancer recurrence
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: mTF levels association
Number of subjects: 243
Study: 7752590

Group type: EXPERIMENTAL
Intervention: Dietary NaCl restriction (5 +/- 3 mmol/day) during KCl deprivation (−67 mmol/day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dietary NaCl restriction (5 +/- 3 mmol/day) during KHCO3 deprivation (−64 mmol/day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Restoration of KCl to the diets
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Restoration of KHCO3 to the diets
Number of subjects: 10
Study: 2097486

Group type: EXPERIMENTAL
Intervention: Flumazenil (0.2 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Thiopental (300 mg)
Number of subjects: 80
Study: 7023166

Group type: EXPERIMENTAL
Intervention: Cimetidine (1,200 mg daily)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 30612325

Group type: EXPERIMENTAL
Intervention: Probiotic supplements for 4 months
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo supplements for 4 months
Number of subjects: 46
Study: 26978327

Group type: EXPERIMENTAL
Intervention: Memantine ER (3 to 15 mg/day based on body weight)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Memantine ER
Number of subjects: 121
Study: 25982134

Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate (30 mg kg(‐1)) with FIBTEM MCF trigger <13 mm (early substitution)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Fibrinogen concentrate (30 mg kg(‐1)) with FIBTEM MCF trigger <8 mm (conventional)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate (30 mg kg(‐1))
Number of subjects: 49
Study: 23454226

Group type: EXPERIMENTAL
Intervention: Silicone-based denture liners
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (acrylic resin)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Denture stomatitis patients with silicone-based denture liners
Number of subjects: 30
Study: 20945114

Group type: EXPERIMENTAL
Intervention: Augmented intervention
Number of subjects: 845

Group type: COMPARATOR
Intervention: Basic intervention
Number of subjects: 845
Study: 19877063

Group type: EXPERIMENTAL
Intervention: teriparatide (20 microg/day)
Number of subjects: 428

Group type: COMPARATOR
Intervention: alendronate (10 mg/day)
Number of subjects: 428
Study: 17122617

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IP) with inflow occlusion
Number of subjects: 73

Group type: COMPARATOR
Intervention: Intermittent clamping (IC)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Both groups (IP and IC)
Number of subjects: 73
Study: 14767298

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 11778119

Group type: EXPERIMENTAL
Intervention: Sufentanil (intravenous and epidural)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Sufentanil in combination with local anaesthetics (ropivacaine, bupivacaine)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Sufentanil with adjuvant drugs (clonidine, ketamine, adrenaline)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Various administration methods (PCA, PCEA, fixed intervals doses, continuous infusion)
Number of subjects: 24
Study: 9233591

Group type: EXPERIMENTAL
Intervention: Ifosphamide, etoposide and epirubicin (IVE) plus G-CSF
Number of subjects: 66

Group type: COMPARATOR
Intervention: Cyclophosphamide plus G-CSF
Number of subjects: 66